These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16958350)

  • 1. Bad medicine. Big Pharma's cash injections lead to poor ethical outcomes.
    Sloane T
    Mod Healthc; 2006 Aug; 36(31):19. PubMed ID: 16958350
    [No Abstract]   [Full Text] [Related]  

  • 2. Big pharma's struggles might benefit health plans.
    Manag Care; 2012 Jan; 21(1):65. PubMed ID: 22334941
    [No Abstract]   [Full Text] [Related]  

  • 3. The perfect mix for your portfolio.
    Simons J
    Fortune; 2003 Dec; 148(13):134-8. PubMed ID: 14712541
    [No Abstract]   [Full Text] [Related]  

  • 4. PBMs come out swinging. Ads say drugmakers are trying to bypass discounts.
    Becker C
    Mod Healthc; 2004 Nov; 34(47):14. PubMed ID: 15624295
    [No Abstract]   [Full Text] [Related]  

  • 5. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

  • 6. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharma's bad karma. Resistance is not futile.
    Carrasquillo O; Goodman RL
    J Gen Intern Med; 2003 Apr; 18(4):315-6. PubMed ID: 12709101
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond the naïve "no-see": ethical prescribing and the drive for pharmaceutical transparency.
    Oldani M
    PM R; 2009 Jan; 1(1):82-6. PubMed ID: 19627878
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry influence. Big Pharma's long tentacles.
    Aldis WL
    BMJ; 2010 Feb; 340():c941. PubMed ID: 20160329
    [No Abstract]   [Full Text] [Related]  

  • 10. Payers may cloud pharma's sunny outlook.
    Manag Care; 2015 Jul; 24(7):45. PubMed ID: 26281472
    [No Abstract]   [Full Text] [Related]  

  • 11. Wisdom from big pharma's Dr. Gloom. Interview by Abrahm Lustgarten.
    Garnier JP
    Fortune; 2005 Mar; 151(6):38. PubMed ID: 15782880
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 13. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly.
    DoBias M
    Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmas work to cover 'doughnut hole' for low-income benes.
    Med Health; 2006 Mar; 60(11):1, 5. PubMed ID: 16544393
    [No Abstract]   [Full Text] [Related]  

  • 15. Big Pharma's small wonder.
    Fry E
    Fortune; 2014 Jun; 169(8):178-84, 186. PubMed ID: 25211849
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 17. The new Medicare drug benefit and related reforms: part II.
    Fuchs B; James J
    Bull Am Coll Surg; 2004 May; 89(5):8-10. PubMed ID: 18435102
    [No Abstract]   [Full Text] [Related]  

  • 18. $50 M for drug comparisons could produce valuable results.
    Carroll J
    Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713
    [No Abstract]   [Full Text] [Related]  

  • 19. Everybody wants to close the doughnut hole.
    Sipkoff M
    Manag Care; 2009 Nov; 18(11):17-8. PubMed ID: 19999248
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing Big Pharma's books.
    Jack A
    BMJ; 2008 Feb; 336(7641):418-9. PubMed ID: 18292166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.